Old news by now, but I thought it should be memorialized here all the same.
Frances O. Kennedy (http://www.nytimes.com/2015/08/08/science/frances-oldham-kelsey-fda-doctor-who-exposed-danger-of-thalidomide-dies-at-101.html), antibusiness flunky.
Watch out, Hatch (https://www.sciencebasedmedicine.org/utahs-senator-orrin-hatch-defender-of-the-supplement-industry/); it's going to take a while to get a signal to Kolob.
Quoth Megan McArdle (http://www.theatlantic.com/business/archive/2008/09/rethinking-regulation/4119/):
QuoteThe FDA is notoriously risk averse when it comes to new drugs, a legacy of events like the Thalidomide horrors, when pointless foot-dragging on the approval accidentally protected American mothers from limbless babies.
Yes, asking whether it could cross the placenta is so typically...
Progressive. Time to unwind that whole "clinical trials" rigamarole.
Quote from: Wheezer on August 10, 2015, 04:59:13 PM
Quoth Megan McArdle (http://www.theatlantic.com/business/archive/2008/09/rethinking-regulation/4119/):
QuoteThe FDA is notoriously risk averse when it comes to new drugs, a legacy of events like the Thalidomide horrors, when pointless foot-dragging on the approval accidentally protected American mothers from limbless babies.
Yes, asking whether it could cross the placenta is so typically... Progressive. Time to unwind that whole "clinical trials" rigamarole.
QuoteMoreover, though it may sound un-libertarian, I'm not clear why the companies are in charge of the drug testing
Um...speaking as a former employee of a CRO, they usually aren't. They just finance the thing. A third party runs the testing.